My NCBI | Sign In
RSS Settings
  • Search:

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 673

    1.

    Is atherosclerosis in diabetes and impaired fasting glucose driven by elevated LDL cholesterol or by decreased HDL cholesterol?

    Drexel H, Aczel S, Marte T, Benzer W, Langer P, Moll W, Saely CH.

    Diabetes Care. 2005 Jan;28(1):101-7.PMID: 15616241 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    A 52-week, randomized, open-label, parallel-group comparison of the tolerability and effects of pitavastatin and atorvastatin on high-density lipoprotein cholesterol levels and glucose metabolism in Japanese patients with elevated levels of low-density lipoprotein cholesterol and glucose intolerance.

    Sasaki J, Ikeda Y, Kuribayashi T, Kajiwara K, Biro S, Yamamoto K, Ageta M, Kobori S, Saikawa T, Otonari T, Kono S.

    Clin Ther. 2008 Jun;30(6):1089-101.PMID: 18640465 [PubMed - indexed for MEDLINE]Related articles

    3.

    [Appearance of undiagnosed diabetes mellitus in the population of professionally active people in the urban areas]

    Wierusz-Wysocka B, Zozulińska D, Knast B, Pisarczyk-Wiza D.

    Pol Arch Med Wewn. 2001 Sep;106(3):815-21. Polish. PMID: 11928591 [PubMed - indexed for MEDLINE]Related articles

    4.

    Serum lipids and glucose control: the SEARCH for Diabetes in Youth study.

    Petitti DB, Imperatore G, Palla SL, Daniels SR, Dolan LM, Kershnar AK, Marcovina S, Pettitt DJ, Pihoker C; SEARCH for Diabetes in Youth Study Group.

    Arch Pediatr Adolesc Med. 2007 Feb;161(2):159-65.PMID: 17283301 [PubMed - indexed for MEDLINE]Related articlesFree article

    5.

    New diagnostic criteria for diabetes and coronary artery disease: insights from an angiographic study.

    Ledru F, Ducimetière P, Battaglia S, Courbon D, Beverelli F, Guize L, Guermonprez JL, Diébold B.

    J Am Coll Cardiol. 2001 May;37(6):1543-50.PMID: 11345363 [PubMed - indexed for MEDLINE]Related articles

    6.

    Triglyceride as a risk factor for coronary artery disease.

    Gotto AM Jr.

    Am J Cardiol. 1998 Nov 5;82(9A):22Q-25Q. Review.PMID: 9819100 [PubMed - indexed for MEDLINE]Related articles

    7.

    Elevated remnant-like lipoprotein particles in impaired glucose tolerance and type 2 diabetic patients.

    Watanabe N, Taniguchi T, Taketoh H, Kitagawa Y, Namura H, Yoneda N, Kurimoto Y, Yamada S, Ishikawa Y.

    Diabetes Care. 1999 Jan;22(1):152-6.PMID: 10333918 [PubMed - indexed for MEDLINE]Related articlesFree article

    8.

    Dyslipidemia and hyperglycemia predict coronary heart disease events in middle-aged patients with NIDDM.

    Lehto S, Rönnemaa T, Haffner SM, Pyörälä K, Kallio V, Laakso M.

    Diabetes. 1997 Aug;46(8):1354-9.PMID: 9231662 [PubMed - indexed for MEDLINE]Related articles

    9.

    Low-density lipoprotein size and subclasses are markers of clinically apparent and non-apparent atherosclerosis in type 2 diabetes.

    Berneis K, Jeanneret C, Muser J, Felix B, Miserez AR.

    Metabolism. 2005 Feb;54(2):227-34.PMID: 15690318 [PubMed - indexed for MEDLINE]Related articles

    10.

    Apolipoprotein B but not LDL cholesterol is associated with coronary artery calcification in type 2 diabetic whites.

    Martin SS, Qasim AN, Mehta NN, Wolfe M, Terembula K, Schwartz S, Iqbal N, Schutta M, Bagheri R, Reilly MP.

    Diabetes. 2009 Aug;58(8):1887-92. Epub 2009 Jun 2.PMID: 19491209 [PubMed - indexed for MEDLINE]Related articlesFree article

    11.

    Ratio of triglycerides to HDL cholesterol is an indicator of LDL particle size in patients with type 2 diabetes and normal HDL cholesterol levels.

    Boizel R, Benhamou PY, Lardy B, Laporte F, Foulon T, Halimi S.

    Diabetes Care. 2000 Nov;23(11):1679-85.PMID: 11092292 [PubMed - indexed for MEDLINE]Related articlesFree article

    12.

    Lipid levels and peripheral vascular disease in diabetic and non-diabetic subjects.

    O'Neal DN, Lewicki J, Ansari MZ, Matthews PG, Best JD.

    Atherosclerosis. 1998 Jan;136(1):1-8.PMID: 9544725 [PubMed - indexed for MEDLINE]Related articles

    13.

    Ethnicity and glycaemic control are major determinants of diabetic dyslipidaemia in Malaysia.

    Ismail IS, Nazaimoon W, Mohamad W, Letchuman R, Singaraveloo M, Hew FL, Shuguna C, Khalid BA.

    Diabet Med. 2001 Jun;18(6):501-8.PMID: 11472471 [PubMed - indexed for MEDLINE]Related articles

    14.

    Regulation of low-density lipoprotein particle size distribution in NIDDM and coronary disease: importance of serum triglycerides.

    Lahdenperä S, Syvänne M, Kahri J, Taskinen MR.

    Diabetologia. 1996 Apr;39(4):453-61.PMID: 8777995 [PubMed - indexed for MEDLINE]Related articles

    15.

    Plasma lipid levels at diagnosis in type 2 diabetic patients.

    Sosenko JM, Kato M, Soto R, Goldberg RB.

    Diabet Med. 1993 Nov;10(9):814-9.PMID: 8281725 [PubMed - indexed for MEDLINE]Related articles

    16.

    MspI polymorphism at +83 bp in intron 1 of the human apolipoprotein A1 gene is associated with elevated levels of HDL cholesterol and apolipoprotein A1 in nondiabetic subjects but not in type 2 diabetic patients with coronary heart disease.

    Pulkkinen A, Viitanen L, Kareinen A, Lehto S, Laakso M.

    Diabetes Care. 2000 Jun;23(6):791-5.PMID: 10840998 [PubMed - indexed for MEDLINE]Related articlesFree article

    17.

    Circulating E-selectin, vascular cell adhesion molecule-1, and intercellular adhesion molecule-1 in men with coronary artery disease assessed by angiography and disturbances of carbohydrate metabolism.

    Kowalska I, Straczkowski M, Szelachowska M, Kinalska I, Prokop J, Bachórzewska-Gajewska H, Stepien A.

    Metabolism. 2002 Jun;51(6):733-6.PMID: 12037726 [PubMed - indexed for MEDLINE]Related articles

    18.

    Reduced coronary events in simvastatin-treated patients with coronary heart disease and diabetes or impaired fasting glucose levels: subgroup analyses in the Scandinavian Simvastatin Survival Study.

    Haffner SM, Alexander CM, Cook TJ, Boccuzzi SJ, Musliner TA, Pedersen TR, Kjekshus J, Pyörälä K.

    Arch Intern Med. 1999 Dec 13-27;159(22):2661-7.PMID: 10597756 [PubMed - indexed for MEDLINE]Related articlesFree article

    19.

    Plasma oxidizability in subjects with normal glucose tolerance, impaired glucose tolerance, and NIDDM.

    Haffner SM, Agil A, Mykkanen L, Stern MP, Jialal I.

    Diabetes Care. 1995 May;18(5):646-53.PMID: 8586002 [PubMed - indexed for MEDLINE]Related articles

    20.

    Cardiovascular risk factors and LDL subfraction profile in Type 2 diabetes mellitus subjects with good glycaemic control.

    Tan CE, Chew LS, Chio LF, Tai ES, Lim HS, Lim SC, Jayakumar L, Eng HK, Packard CJ.

    Diabetes Res Clin Pract. 2001 Feb;51(2):107-14.PMID: 11165690 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Filter your results:

    Find related data

    Recent activity